相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A homeostatic clock sets daughter centriole size in flies
Mustafa G. Aydogan et al.
JOURNAL OF CELL BIOLOGY (2018)
Fast and furious ... or not, Plk4 dictates the pace
Simon Gemble et al.
JOURNAL OF CELL BIOLOGY (2018)
An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly
Tiffany A. McLamarrah et al.
JOURNAL OF CELL BIOLOGY (2018)
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
Masanori Kawakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
CFI-400945 is not a selective cellular PLK4 inhibitor
Karen Oegema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Defining a Cancer Dependency Map
Aviad Tsherniak et al.
CELL (2017)
Reversible centriole depletion with an inhibitor of Polo-like kinase 4
Yao Liang Wong et al.
SCIENCE (2015)
The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent
Peter B. Sampson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents
Peter B. Sampson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
Andrew J. Holland et al.
CANCER CELL (2014)
Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
Jacqueline M. Mason et al.
CANCER CELL (2014)
Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer
Dmitri Mouradov et al.
CANCER RESEARCH (2014)
Oncogene-like induction of cellular invasion from centrosome amplification
Susana A. Godinho et al.
NATURE (2014)
Polo-like kinases: structural variations lead to multiple functions
Sihem Zitouni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
Radoslaw Laufer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Molecular control of animal cell cytokinesis
Juan Pablo Fededa et al.
NATURE CELL BIOLOGY (2012)
Ponatinib for Chronic Myeloid Leukemia
John M. Goldman
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Structure of the Plk4 Cryptic Polo Box Reveals Two Tandem Polo Boxes Required for Centriole Duplication
Lauren K. Slevin et al.
STRUCTURE (2012)
Mitotic Kinases and p53 Signaling
Geun-Hyoung Ha et al.
BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)
From Plk1 to Plk5 Functional evolution of Polo-like kinases
Guillermo de Carcer et al.
CELL CYCLE (2011)
Anaphase Catastrophe Is a Target for Cancer Therapy
Fabrizio Galimberti et al.
CLINICAL CANCER RESEARCH (2011)
Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
Gottfried E. Konecny et al.
CLINICAL CANCER RESEARCH (2011)
Rapid and enhanced proteolytic digestion using electric-field-oriented enzyme reactor
Yu Zhou et al.
JOURNAL OF PROTEOMICS (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Functional Viability Profiles of Breast Cancer
Rachel Brough et al.
CANCER DISCOVERY (2011)
Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe
Fabrizio Galimberti et al.
CLINICAL CANCER RESEARCH (2010)
Autophosphorylation of Polo-like Kinase 4 and Its Role in Centriole Duplication
James E. Sillibourne et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Yan Degenhardt et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Plk4 is required for cytokinesis and maintenance of chromosomal stability
Carla O. Rosario et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Polo-like kinase 4: the odd one out of the family
James E. Sillibourne et al.
CELL DIVISION (2010)
γ-Tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells
Ryoko Kuriyama et al.
JOURNAL OF CELL SCIENCE (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis
Pascal Finetti et al.
CANCER RESEARCH (2008)
Abelson interactor protein-1 positively regulates breast cancer cell proliferation, migration, and invasion
Chunjie Wang et al.
MOLECULAR CANCER RESEARCH (2007)
Chromosomal passengers: conducting cell division
Sandrine Ruchaud et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
SAK/PLK4 is required for centriole duplication and flagella development
M Bettencourt-Dias et al.
CURRENT BIOLOGY (2005)
RNA-dependent integrin α3 protein localization regulated by the Muscleblind-like protein MLP1
Y Adereth et al.
NATURE CELL BIOLOGY (2005)
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
MA Ko et al.
NATURE GENETICS (2005)
The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization
GC Leung et al.
NATURE STRUCTURAL BIOLOGY (2002)
Proteasome inhibitors: from research tools to drug candidates
AF Kisselev et al.
CHEMISTRY & BIOLOGY (2001)
Late mitotic failure in mice lacking Sak, a polo-like kinase
JW Hudson et al.
CURRENT BIOLOGY (2001)
分享论文
